Vigilant monitoring is needed to manage cardiac risks in patients using antipsychotics, doctors say

A study in Heart Rhythm reports a connection between antipsychotic drugs quetiapine and haloperidol and an increased risk of serious cardiac conditions such as ventricular arrhythmias and sudden cardiac death. The use of these medications is common, so health care professionals and patients need to be aware of these cardiac risks and implement appropriate monitoring and risk mitigation strategies. Research in Taiwan showed that over 10% of patients developed severe QT prolongation after treatment with these antipsychotic drugs, with a subsequent increase in the risk of severe cardiac conditions. The editorial accompanying the study emphasizes the need for vigilant monitoring and careful consideration of the risks associated with these medications.

Source link

error: Content is protected !!